92 related articles for article (PubMed ID: 32867645)
41. Computer-aided Drug Discovery Approaches in the Identification of Natural Products against SARS-CoV-2: A Review.
Junqueira Ribeiro MM
Curr Comput Aided Drug Des; 2024; 20(4):313-324. PubMed ID: 36999423
[TBL] [Abstract][Full Text] [Related]
42. Antiviral nanoparticle ligands identified with datamining and high-throughput virtual screening.
Booker EP; Jabbour GE
RSC Adv; 2021 Jun; 11(37):23136-23143. PubMed ID: 35480438
[TBL] [Abstract][Full Text] [Related]
43. Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2.
Núñez MJ; Díaz-Eufracio BI; Medina-Franco JL; Olmedo DA
RSC Adv; 2021 Apr; 11(26):16051-16064. PubMed ID: 35481202
[TBL] [Abstract][Full Text] [Related]
44. Antiviral natural products and herbal medicines.
Lin LT; Hsu WC; Lin CC
J Tradit Complement Med; 2014 Jan; 4(1):24-35. PubMed ID: 24872930
[TBL] [Abstract][Full Text] [Related]
45. Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors.
Gao S; Huang T; Song L; Xu S; Cheng Y; Cherukupalli S; Kang D; Zhao T; Sun L; Zhang J; Zhan P; Liu X
Acta Pharm Sin B; 2022 Feb; 12(2):581-599. PubMed ID: 34485029
[TBL] [Abstract][Full Text] [Related]
46. 'BhAVI-23'-A spice-herb based dietary infusion possessing in-vitro anti-viral potential.
Saxena S; Kumar S; Hajare SN; Gupta S; Gautam S; Ghosh SK
J Ayurveda Integr Med; 2021; 12(2):312-319. PubMed ID: 33413968
[TBL] [Abstract][Full Text] [Related]
47. Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19.
Sakkiah S; Singh BK; Lee KW; Selvaraj C
Front Pharmacol; 2022; 13():852078. PubMed ID: 35359860
[No Abstract] [Full Text] [Related]
48. What is the role of cheminformatics in a pandemic?
Guha R; Willighagen E; Zdrazil B; Jeliazkova N
J Cheminform; 2021 Mar; 13(1):16. PubMed ID: 33653411
[No Abstract] [Full Text] [Related]
49. Author Correction: High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2.
Chan CWF; Wang B; Nan L; Huang X; Mao T; Chu HY; Luo C; Chu H; Choi GCG; Shum HC; Wong ASL
Nat Biomed Eng; 2024 Mar; 8(3):336. PubMed ID: 38267642
[No Abstract] [Full Text] [Related]
50. Corrigendum to "Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics" "Antiviral Research 209 (2023)/105484".
Perez-Vargas J; Shapira T; Olmstead AD; Villanueva I; Thompson CAH; Ennis S; Gao G; De Guzman J; Williams DE; Wang M; Chin A; Bautista-Sanchez D; Agafitei O; Levett P; Xie X; Nuzzo G; Freire VF; Quintana-Bulla JI; Bernardi DI; Gubiani JR; Suthiphasilp V; Raksat A; Meesakul P; Polbuppha I; Cheenpracha S; Jaidee W; Kanokmedhakul K; Yenjai C; Chaiyosang B; Teles HL; Manzo E; Fontana A; Leduc R; Boudreault PL; Berlinck RGS; Laphookhieo S; Kanokmedhakul S; Tietjen I; Cherkasov A; Krajden M; Nabi IR; Niikura M; Shi PY; Andersen RJ; Jean F
Antiviral Res; 2023 May; 213():105577. PubMed ID: 37002158
[No Abstract] [Full Text] [Related]
51. Smoking and COVID-19: Adding Fuel to the Flame.
Kashyap VK; Dhasmana A; Massey A; Kotnala S; Zafar N; Jaggi M; Yallapu MM; Chauhan SC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916821
[TBL] [Abstract][Full Text] [Related]
52.
Kashyap VK; Dhasmana A; Yallapu MM; Chauhan SC; Jaggi M
Future Drug Discov; 2020 Oct; 2(4):FDD50. PubMed ID: 33269342
[No Abstract] [Full Text] [Related]
53.
Teli DM; Shah MB; Chhabria MT
Front Mol Biosci; 2020; 7():599079. PubMed ID: 33542917
[TBL] [Abstract][Full Text] [Related]
54. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
55. The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV-2 targets.
Parida PK; Paul D; Chakravorty D
Phytother Res; 2020 Dec; 34(12):3420-3433. PubMed ID: 32969524
[TBL] [Abstract][Full Text] [Related]
56. Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I).
Kamal MA; Khan MA
Curr Pharm Des; 2020; 26(41):5221-5223. PubMed ID: 33327907
[No Abstract] [Full Text] [Related]
57. Be aware of SARS-CoV-2 spike protein: There is more than meets the eye.
Theoharides TC; Conti P
J Biol Regul Homeost Agents; 2021; 35(3):833-838. PubMed ID: 34100279
[TBL] [Abstract][Full Text] [Related]
58. N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative group.
Paridaens R; Mouridsen HT; Palshof T; Cocconi G; Van Oosterom A; Rotmensz N; Sylvester R; Heuson JC; Rozencweig M
Eur J Cancer Clin Oncol; 1982 Jan; 18(1):67-70. PubMed ID: 6211361
[TBL] [Abstract][Full Text] [Related]
59. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.
Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH
Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466
[TBL] [Abstract][Full Text] [Related]
60. Phase I trial of N-(Phosphonacetyl)-L-aspartic acid (PALA).
Ervin TJ; Blum RH; Meshad MW; Kufe DW; Johnson RK; Canellos GP
Cancer Treat Rep; 1980; 64(10-11):1067-71. PubMed ID: 7459892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
